Literature DB >> 935632

Fenfluramine-induced hyperthermia and stimulation in the rabbit.

R M Quock, G A Beal.   

Abstract

Fenfluramine produces dose-related hyperthermia and behavioral stimulation in rabbits following intravenous administration. Both responses were antagonized by pretreatment with cinanserin, cyproheptadine, or fluxetine. Methergoline likewise abolished the stimulatory effect of fenfluramine and produced a partial blockade of the hyperthermia. Haloperidol was ineffective as a fenfluramine antagonist. This study demonstrates that fenfluramine-induced hyperthermia and stimulation in the rabbit result from an indirect action upon serotonergic receptors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 935632

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  6 in total

1.  Evidence for a receptor supersensitivity following impairment of central serotoninergic activity in the rabbit.

Authors:  M O Carruba; G Nisticó; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

2.  Trazodone, a central serotonin antagonist and agonist.

Authors:  J Maj; W Palider
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

3.  The influence of bromocriptine on serotonin neurons.

Authors:  J Maj; L Gancarczyk; A Rawlów
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

4.  The central antiserotonergic action of mianserin.

Authors:  J Maj; H Sowińska; L Baran; L Gancarczyk; A Rawłów
Journal:  Psychopharmacology (Berl)       Date:  1978-09-15       Impact factor: 4.530

5.  Anorexigenic and ancillary actions of MK-212 (6-chloro-2-(1-piperazinyl)-pyrazine; CPP).

Authors:  B V Clineschmidt; H M Hanson; A B Pflueger; J C McGuffin
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

Review 6.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

Authors:  P Benfield; R C Heel; S P Lewis
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.